BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lonati C, Bassani GA, Brambilla D, Leonardi P, Carlin A, Maggioni M, Zanella A, Dondossola D, Fonsato V, Grange C, Camussi G, Gatti S. Mesenchymal stem cell-derived extracellular vesicles improve the molecular phenotype of isolated rat lungs during ischemia/reperfusion injury. J Heart Lung Transplant 2019;38:1306-16. [PMID: 31530458 DOI: 10.1016/j.healun.2019.08.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Karamanos NK, Piperigkou Z, Passi A, Götte M, Rousselle P, Vlodavsky I. Extracellular matrix-based cancer targeting. Trends Mol Med 2021:S1471-4914(21)00190-8. [PMID: 34389240 DOI: 10.1016/j.molmed.2021.07.009] [Reference Citation Analysis]
2 Gori F, Fumagalli J, Lonati C, Carlin A, Leonardi P, Biancolilli O, Rossetti A, Righi I, Tosi D, Palleschi A, Rosso L, Morlacchi LC, Blasi F, Vivona L, Florio G, Scaravilli V, Valenza F, Zanella A, Grasselli G. Lung Biomolecular Profile and Function of Grafts from Donors after Cardiocirculatory Death with Prolonged Donor Warm Ischemia Time. JCM 2022;11:3066. [DOI: 10.3390/jcm11113066] [Reference Citation Analysis]
3 Pang LX, Cai WW, Li Q, Li HJ, Fei M, Yuan YS, Sheng B, Zhang K, An RC, Ou YW, Zeng WJ. Bone marrow-derived mesenchymal stem cells attenuate myocardial ischemia-reperfusion injury via upregulation of splenic regulatory T cells. BMC Cardiovasc Disord 2021;21:215. [PMID: 33906602 DOI: 10.1186/s12872-021-02007-4] [Reference Citation Analysis]
4 Iske J, Hinze CA, Salman J, Haverich A, Tullius SG, Ius F. The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury. Am J Transplant 2021. [PMID: 34355495 DOI: 10.1111/ajt.16784] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
5 Lonati C, Schlegel A, Battistin M, Merighi R, Carbonaro M, Dongiovanni P, Leonardi P, Zanella A, Dondossola D. Effluent Molecular Analysis Guides Liver Graft Allocation to Clinical Hypothermic Oxygenated Machine Perfusion. Biomedicines 2021;9:1444. [PMID: 34680561 DOI: 10.3390/biomedicines9101444] [Reference Citation Analysis]
6 Prasad NK, Pasrija C, Talaie T, Krupnick AS, Zhao Y, Lau CL. Ex Vivo Lung Perfusion: Current Achievements and Future Directions. Transplantation 2021;105:979-85. [PMID: 33044428 DOI: 10.1097/TP.0000000000003483] [Reference Citation Analysis]
7 Zheng D, Zhou H, Wang H, Zhu Y, Wu Y, Li Q, Li T, Liu L. Mesenchymal stem cell-derived microvesicles improve intestinal barrier function by restoring mitochondrial dynamic balance in sepsis rats. Stem Cell Res Ther 2021;12:299. [PMID: 34039427 DOI: 10.1186/s13287-021-02363-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Dengu F, Abbas SH, Ebeling G, Nasralla D. Normothermic Machine Perfusion (NMP) of the Liver as a Platform for Therapeutic Interventions during Ex-Vivo Liver Preservation: A Review. J Clin Med. 2020;9. [PMID: 32272760 DOI: 10.3390/jcm9041046] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
9 Zhang Y, Zhang X, Zhang H, Song P, Pan W, Xu P, Wang G, Hu P, Wang Z, Huang K, Zhang X, Wang H, Zhang J. Mesenchymal Stem Cells Derived Extracellular Vesicles Alleviate Traumatic Hemorrhagic Shock Induced Hepatic Injury via IL-10/PTPN22-Mediated M2 Kupffer Cell Polarization. Front Immunol 2021;12:811164. [PMID: 35095903 DOI: 10.3389/fimmu.2021.811164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lonati C, Battistin M, Dondossola DE, Bassani GA, Brambilla D, Merighi R, Leonardi P, Carlin A, Meroni M, Zanella A, Catania A, Gatti S. NDP-MSH treatment recovers marginal lungs during ex vivo lung perfusion (EVLP). Peptides 2021;141:170552. [PMID: 33865932 DOI: 10.1016/j.peptides.2021.170552] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Carlson K, Barbas A, Goldaracena N, Fernandez L, Al-Adra DP. Immunological organ modification during Ex Vivo machine perfusion: The future of organ acceptance. Transplant Rev (Orlando) 2021;35:100586. [PMID: 33876730 DOI: 10.1016/j.trre.2020.100586] [Reference Citation Analysis]
12 Chen-Yoshikawa TF. Ischemia-Reperfusion Injury in Lung Transplantation. Cells 2021;10:1333. [PMID: 34071255 DOI: 10.3390/cells10061333] [Reference Citation Analysis]
13 Tejeda-Mora H, Leon LG, Demmers J, Baan CC, Reinders MEJ, Bleck B, Lombardo E, Merino A, Hoogduijn MJ. Proteomic Analysis of Mesenchymal Stromal Cell-Derived Extracellular Vesicles and Reconstructed Membrane Particles. Int J Mol Sci 2021;22:12935. [PMID: 34884740 DOI: 10.3390/ijms222312935] [Reference Citation Analysis]
14 Miller CL, O JM, Allan JS, Madsen JC. Novel approaches for long-term lung transplant survival. Front Immunol 2022;13:931251. [DOI: 10.3389/fimmu.2022.931251] [Reference Citation Analysis]
15 Sailliet N, Ullah M, Dupuy A, Silva AKA, Gazeau F, Le Mai H, Brouard S. Extracellular Vesicles in Transplantation. Front Immunol 2022;13:800018. [PMID: 35185891 DOI: 10.3389/fimmu.2022.800018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Dondossola D, Santini A, Lonati C, Zanella A, Merighi R, Vivona L, Battistin M, Galli A, Biancolilli O, Maggioni M, Villa S, Gatti S. Human Red Blood Cells as Oxygen Carriers to Improve Ex-Situ Liver Perfusion in a Rat Model. J Clin Med 2019;8:E1918. [PMID: 31717387 DOI: 10.3390/jcm8111918] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
17 Zhang X, Lu Y, Wu S, Zhang S, Li S, Tan J. An Overview of Current Research on Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Bibliometric Analysis From 2009 to 2021. Front Bioeng Biotechnol 2022;10:910812. [DOI: 10.3389/fbioe.2022.910812] [Reference Citation Analysis]
18 Grange C, Bellucci L, Bussolati B, Ranghino A. Potential Applications of Extracellular Vesicles in Solid Organ Transplantation. Cells. 2020;9. [PMID: 32033489 DOI: 10.3390/cells9020369] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
19 Cai J, Gehrau R, Tu Z, Leroy V, Su G, Shang J, Mas VR, Emtiazjoo A, Pelaez A, Atkinson C, Machuca T, Upchurch GR Jr, Sharma AK. MicroRNA-206 antagomiR‒enriched extracellular vesicles attenuate lung ischemia‒reperfusion injury through CXCL1 regulation in alveolar epithelial cells. J Heart Lung Transplant 2020;39:1476-90. [PMID: 33067103 DOI: 10.1016/j.healun.2020.09.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Li J, Peng Q, Yang R, Li K, Zhu P, Zhu Y, Zhou P, Szabó G, Zheng S. Application of Mesenchymal Stem Cells During Machine Perfusion: An Emerging Novel Strategy for Organ Preservation. Front Immunol 2021;12:713920. [PMID: 35024039 DOI: 10.3389/fimmu.2021.713920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Niroomand A, Hirdman G, Olm F, Lindstedt S. Current Status and Future Perspectives on Machine Perfusion: A Treatment Platform to Restore and Regenerate Injured Lungs Using Cell and Cytokine Adsorption Therapy. Cells 2021;11:91. [PMID: 35011653 DOI: 10.3390/cells11010091] [Reference Citation Analysis]
22 Wu Y, Zhang C, Guo R, Wu D, Shi J, Li L, Chu Y, Yuan X, Gao J. Mesenchymal Stem Cells: An Overview of Their Potential in Cell-Based Therapy for Diabetic Nephropathy. Stem Cells Int 2021;2021:6620811. [PMID: 33815509 DOI: 10.1155/2021/6620811] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Iske J, Matsunaga T, Zhou H, Tullius SG. Donor and Recipient Age-Mismatches: The Potential of Transferring Senescence. Front Immunol 2021;12:671479. [PMID: 33995411 DOI: 10.3389/fimmu.2021.671479] [Reference Citation Analysis]
24 Zhou W, Lin D, Zhong Z, Ye Q. Roles of TRAFs in Ischemia-Reperfusion Injury. Front Cell Dev Biol 2020;8:586487. [PMID: 33224951 DOI: 10.3389/fcell.2020.586487] [Reference Citation Analysis]
25 Miceli V, Bertani A. Mesenchymal Stromal/Stem Cells and Their Products as a Therapeutic Tool to Advance Lung Transplantation. Cells 2022;11:826. [DOI: 10.3390/cells11050826] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]